Lisa M Wintner and colleagues show that giving clinicians access to EORTC patient-reported outcome (PRO) data during assessment with Common Terminology Criteria for Adverse Events (CTCAE) significantly increased inter-rater reliability for 13 of 17 symptomatic adverse events, with the largest gains in cognitive and psychological domains.1 This pragmatic multinational trial provides timely evidence for integrating PROs into safety assessment workflows.
The Lancet Oncology published a clinical update in Oncology on 01 Apr 2026.
The item focuses on From reliability to implementable toxicity policy in PRO-informed CTCAE.
Review the original article for the full source wording and details.